Recent Prospectives of Anticancer Histone Deacetylase Inhibitors

HDAC as a cancer target: Various scaffolds based on HDAC inhibitors and an overview of their advances

Advances in non-Hydroxamate based Histone Deacetylase Inhibitors as Anticancer Agents

Histone Deacetylase Inhibitors in Cancer

Recent advances in dual-targeting HDAC inhibitors for cancer treatment

Design, synthesis, molecular docking study, and biological evaluation of salicylaldimine derivatives as potential histone deacetylases inhibitors (HDACi) and anticancer agents

Design ,Synthesis, Insilco Study and Biological Evaluation of New Coumarin-Oxadiazole Derivatives as Potent Histone Deacetylase Inhibitors

Coumarin based-histone deactylace HADC inhibitors

Design, molecular docking, synthesis, and in vitro pharmacological evaluation of biomolecules-histone deacetylase inhibitors conjugates with carbohydrazide as a novel zinc-binding

Identification of Novel 4-Oxo-4H-chromen-Hydroxamic Acid Derivative Targeting Selected HDAC Isoforms